Author

U. Klingmüller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Assay:fluorescence / live-cell microscopy· 1 Research Focus:protein folding & dynamics· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Schulze· 1 shared A.-K. Daum· 1 shared D.-P. Herten· 1 shared F. Hild· 1 shared F. Schwörer· 1 shared H. Sültmann· 1 shared J. Euchner· 1 shared J. Hummert· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Schulze

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A General Method to Accurately Count Molecular Complexes and Determine the Degree of Labelling in Cells Using Protein Tags

S. A. Tashev, J. Euchner, K. Yserentant, S. Hänselmann, F. Hild, W. Chmielewicz, J. Hummert, F. Schwörer, N. Tsopoulidis, S. Germer, Z. Sassmannshausen, O. T. Fackler, U. Klingmüller, D.-P. Herten

This paper introduces ProDOL, a method to measure degree of labelling in cells using protein tags, and applies it to study HIV-1 Nef's effect on CD4 T cell activation.

bioRxiv · Sep 8, 2023 · PreprintCell Biology

Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis

A.-K. Daum, L. Schlicker, M. A. Schneider, T. Muley, U. Klingmüller, A. Schulze, M. Thomas, P. Christopoulos, H. Sültmann

This study shows cancer-associated fibroblasts enhance drug resistance in ALK-driven lung adenocarcinoma by promoting lipid biosynthesis and suppressing lipid peroxidation through AKT signaling.

bioRxiv · Aug 8, 2023 · PreprintCancer Biology